Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Stericycle Inc    SRCL   US8589121081

STERICYCLE INC (SRCL)

7
Delayed Quote. Delayed Nasdaq - 10/21 10:55:45 am
120.59 USD   +1.37%
3d ago STERICYCLE : Ebola Waste Not Coming to Utah
10/10 STERICYCLE : to Participate in Investor Conference in November
10/07 STERICYCLE : Utah Investigates Medical Waste Incinerator
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales1 6761 9132 1432 5562 8243 080
Operating income (EBITDA)510570645740833895
Operating profit (EBIT)444494556622704782
Pre-Tax Profit (EBT)-417478---
Net income235268311350407459
EPS ( $)2,693,083,564,074,745,34
Dividend per Share ( $)------
Yield------
Announcement Date02/02/2012
09:02pm
02/06/2013
09:02pm
02/05/2014
09:02pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt1 3621 3241 3691 5161 143661
Finance------
Operating income (EBITDA)510570645740833895
Leverage
(Debt/EBITDA)
2,67x2,32x2,12x2,05x1,37x0,74x
Capital Expenditure53,365,273,182,288,993,5
Book Value Per Share (BVPS)14,2 $17,9 $20,6 $23,8 $28,1 $34,3 $
Cash Flow per Share-4,45 $4,62 $---
Announcement Date02/02/2012
09:02pm
02/06/2013
09:02pm
02/05/2014
09:02pm
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 10 089 M$ -
Entreprise Value (EV) 11 605 M$ 11 232 M$
Valuation 2014e 2015e
PER (Price / EPS) 29,2x 25,1x
Capitalization / Revenue 3,95x 3,57x
EV / Revenue 4,54x 3,98x
EV / EBITDA 15,7x 13,5x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 24,3% 24,9%
operating Leverage (Delta EBIT / Delta Sales) 0,61x 1,26x
Net Margin (Net Profit / Revenue) 13,7% 14,4%
ROA (Net Profit / Asset) 8,60% 8,90%
ROE (Net Profit / Equities) 19,2% 18,4%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   3,21% 3,15%
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) 1,59x 1,62x
Financial Leverage (Net Debt / EBITDA) 2,05x 1,37x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF